SCN5A and irritable bowel syndrome: A new pathogenic mechanism for IBS-like symptoms was revealed through a collaborative work between researchers in the US and Europe who found that loss-of-function mutations in SCN5A were associated with IBS-like symptoms and that 2.2% of patients with IBS exhibited such mutations (68).